Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-021568-14Phase 3Active
Phase 3, single-arm trial of pramoxine in atopic dermatitis (AD) and pruritus, sponsored by ISDIN. Primary endpoint: Change in pruritus intensity from baseline to end of study (pediatric VAS). Started Jul 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-021568-14.